Drawing for EPIT

USPTO serial 79116353

EPIT

Reviewed by CopyMark Law Group

Reg. 4326432Status 404
Filing date
Status date
Registration date
Apr 30, 2013
Examiner
LEE, JANET H
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with EPIT?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
042Medical research in the field of immunotherapy; medical research, namely, designing a scientific method for desensitization via epicutaneous immunotherapy, without the skin being pre-prepared excluding a light cleaning that leaves the cellular structure of the epidermis intact; scientific research in the field of allergy treatments and therapies; scientific research relating to allergy treatments that are repeatedly applied to the skin without the skin being pre-prepared excluding a light cleaning that leaves the cellular structure of the epidermis intact to prevent the allergen from getting into the blood; medical research, namely, discovery and development of allergens; medical research, namely, designing treatment methods for allergies by associating allergens to immune cells present in the skin; medical research, namely, designing treatment methods for allergies consisting of the application of a patch on the intact skin of the patient without the skin being pre-prepared excluding a light cleaning that leaves the cellular structure of the epidermis intactSECTION 71 - CANCELLED
044Medical services consisting of the application of a desensitization method using immunotherapy; medical treatments comprising the administration of allergens by putting a patch on the intact skin of a patient to prevent the allergen from getting into the blood; medical treatments using desensitization via epicutaneous immunotherapy; epicutaneous medical treatments without the skin being pre-prepared excluding a light cleaning that leaves the cellular structure of the epidermis intact; consulting in the field of medical care, namely, desensitizing against allergiesSECTION 71 - CANCELLED

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 27, 2025DENANOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Aug 27, 2025DETHDEATH OF INTERNATIONAL REGISTRATION
Jul 17, 2024ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB
Jun 20, 2024NREPNEW REPRESENTATIVE AT IB RECEIVED
Jun 17, 2022RNWLINTERNATIONAL REGISTRATION RENEWED
Nov 1, 2021NREPNEW REPRESENTATIVE AT IB RECEIVED
Oct 10, 2020INNTTOTAL INVALIDATION PROCESSED BY THE IB
Sep 14, 2020INTSTOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Sep 14, 2020INPCINVALIDATION PROCESSED
Aug 6, 2020INTRTOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Dec 6, 2019C71TCANCELLED SECTION 71
Apr 30, 2018REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Feb 17, 2017ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB
Feb 19, 2016TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED
Feb 18, 2014FINOFINAL DECISION TRANSACTION PROCESSED BY IB
Jan 8, 2014FICSFINAL DISPOSITION NOTICE SENT TO IB
Jan 8, 2014FIMPFINAL DISPOSITION PROCESSED
Nov 12, 2013ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB
Jul 30, 2013FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Apr 30, 2013R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Mar 4, 2013GPNXNOTIFICATION PROCESSED BY IB
Feb 12, 2013NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 12, 2013PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jan 23, 2013OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jan 23, 2013OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Jan 23, 2013NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 8, 2013PREVLAW OFFICE PUBLICATION REVIEW COMPLETED
Jan 7, 2013ALIEASSIGNED TO LIE
Dec 18, 2012CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Dec 7, 2012TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED
Dec 7, 2012TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Dec 7, 2012CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 7, 2012TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 1, 2012RFNPREFUSAL PROCESSED BY IB
Sep 13, 2012RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Sep 13, 2012RFRRREFUSAL PROCESSED BY MPU
Sep 8, 2012RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Sep 7, 2012CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 7, 2012RFWRNON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW
Sep 7, 2012RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Sep 6, 2012CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 5, 2012DOCKASSIGNED TO EXAMINER
Sep 4, 2012MAFRAPPLICATION FILING RECEIPT MAILED
Aug 31, 2012NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 30, 2012REPRSN ASSIGNED FOR SECT 66A APPL FROM IB

Frequently asked questions

Related guidance